{
    "b0": "Apoptosis in the nervous system",
    "b1": "Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury",
    "b2": "identification of rip1 kinase as a specific cellular target of necrostatins",
    "b3": "Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death",
    "b4": "Necroptosis in development, inflammation and disease",
    "b5": "Necroptosis in development and diseases",
    "b6": "Microglia-targeted candidates push the Alzheimer drug envelope",
    "b7": "Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers",
    "b8": "A first insight into the molecular mechanisms of apoptosis",
    "b9": "Programmed cell death during Caenorhabditis elegans development",
    "b10": "the c. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme",
    "b11": "Prevention of vertebrate neuronal death by the crmA gene",
    "b12": "A decade of caspases",
    "b13": "Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology",
    "b14": "The apoptosome: physiological, developmental, and pathological modes of regulation",
    "b15": "The many roles of FAS receptor signaling in the immune system",
    "b16": "Caspase-8: regulating life and death",
    "b17": "Caspase cleavage sites in the human proteome: CaspDB, a database of predicted substrates",
    "b18": "The protean actions of neurotrophins and their receptors on the life and death of neurons",
    "b19": "Inhibition of apoptotic signaling cascades causes loss of trophic factor dependence during neuronal maturation",
    "b20": "Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice",
    "b21": "Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9",
    "b22": "Dynamics of expression of apoptosis-regulatory proteins Bid, Bcl-2, Bcl-X, Bax and Bak during development of murine nervous system",
    "b23": "Regulation of caspases in the nervous system implications for functions in health and disease",
    "b24": "Mature neurons: equipped for survival",
    "b25": "developmental regulation of mitochondrial apoptosis by c-myc governs age- and tissue-specific sensitivity to cancer therapeutics",
    "b26": "miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis",
    "b27": "Chromatin modification of Apaf-1 restricts the apoptotic pathway in mature neurons",
    "b28": "motoneuron resistance to apoptotic cell death in vivo correlates with the ratio between x-linked inhibitor of apoptosis proteins (xiaps) and its inhibitor, xiap-associated factor 1",
    "b29": "intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in alzheimer disease and vascular dementia",
    "b30": "Intrathecal inflammation precedes development of Alzheimer's disease",
    "b31": "Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis",
    "b32": "CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis",
    "b33": "Cytokines in Parkinson's disease",
    "b34": "association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis",
    "b35": "Neuroinflammatory TNF\u03b1 impairs memory via astrocyte signaling",
    "b36": "Death receptor-ligand systems in cancer, cell death, and inflammation",
    "b37": "Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke",
    "b38": "Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis",
    "b39": "Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)",
    "b40": "TRAIL is expressed in the brain cells of Alzheimer's disease patients",
    "b41": "Multiple sclerosis: death receptor expression and oligodendrocyte apoptosis in established lesions",
    "b42": "A novel role for RIP1 kinase in mediating TNF\u03b1 production",
    "b43": "TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation",
    "b44": "cell death-independent activities of the death receptors cd95, trailr1, and trailr2",
    "b45": "TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects",
    "b46": "Untangling the brain's neuroinflammatory and neurodegenerative transcriptional responses",
    "b47": "An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex",
    "b48": "TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex",
    "b49": "Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes",
    "b50": "Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation",
    "b51": "Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase",
    "b52": "Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3",
    "b53": "MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates",
    "b54": "Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNF\u03b1-mediated apoptosis",
    "b55": "cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination",
    "b56": "Ubiquitination in signaling to and activation of IKK",
    "b57": "Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis",
    "b58": "nf-\u03bab-independent role of ikk\u03b1/ikk\u03b2 in preventing ripk1 kinase-dependent apoptotic and necroptotic cell death during tnf signaling",
    "b59": "MK2 phosphorylates RIPK1 to prevent TNF-induced cell death",
    "b60": "p38mapk/mk2-dependent phosphorylation controls cytotoxic ripk1 signalling in inflammation and\u00a0infection",
    "b61": "SPATA2 links CYLD to LUBAC, activates CYLD, and controls LUBAC signaling",
    "b62": "SPATA2-mediated binding of CYLD to HOIP enables CYLD recruitment to signaling complexes",
    "b63": "spata2 promotes cyld activity and regulates tnf-induced nf-b signaling and cell death",
    "b64": "SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination",
    "b65": "the tumour suppressor cyld negatively regulates nf-kappab signalling by deubiquitination",
    "b66": "cyld is a deubiquitinating enzyme that negatively regulates nf-kappab activation by tnfr family members",
    "b67": "LUBAC-recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes",
    "b68": "Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway",
    "b69": "Cutting edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice",
    "b70": "specific recognition of linear ubiquitin chains by nemo is important for nf-kappab activation",
    "b71": "NF-\u03baB essential modulator (NEMO) interaction with linear and Lys-63 ubiquitin chains contributes to NF-\u03baB activation",
    "b72": "Polyubiquitin binding to ABIN1 is required to prevent autoimmunity",
    "b73": "Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis",
    "b74": "RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS",
    "b75": "ABIN-1 regulates RIPK1 activation by linking Met1 ubiquitylation with Lys63 deubiquitylation in TNF-RSC",
    "b76": "",
    "b77": "Structural insights into the ubiquitin recognition by OPTN (optineurin) and its regulation by TBK1-mediated phosphorylation",
    "b78": "NEMO prevents RIP kinase 1-mediated epithelial cell death and chronic intestinal inflammation by NF-\u03baB-dependent and -independent functions",
    "b79": "tbk1 suppresses ripk1-driven apoptosis and inflammation during development and in aging",
    "b80": "Regulation of NF-\u03baB by deubiquitinases",
    "b81": "Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death",
    "b82": "de-ubiquitination and ubiquitin ligase domains of a20 downregulate nf-kappab signalling",
    "b83": "Ubiquitin binding to A20 ZnF4 is required for modulation of NF-\u03baB signaling",
    "b84": "inhibition of nf-kappab signaling by a20 through disruption of ubiquitin enzyme complexes",
    "b85": "Genetic correlation between amyotrophic lateral sclerosis and schizophrenia",
    "b86": "Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis",
    "b87": "Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis",
    "b88": "Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally",
    "b89": "FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis",
    "b90": "RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3",
    "b91": "ripk1 regulates ripk3-mlkl-driven systemic inflammation and emergency hematopoiesis",
    "b92": "activation of necroptosis in multiple sclerosis",
    "b93": "nf-kappab signals induce the expression of c-flip",
    "b94": "Caspase-8, association with Alzheimer's disease and functional analysis of rare variants",
    "b95": "TRAF2 sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer",
    "b96": "Wallerian degeneration: an emerging axon death pathway linking injury and disease",
    "b97": "Implications of white matter damage in amyotrophic lateral sclerosis (review)",
    "b98": "Review: axon pathology in age-related neurodegenerative disorders",
    "b99": "axonal self-destruction and neurodegeneration",
    "b100": "axon degeneration: molecular mechanisms of a self-destruction pathway",
    "b101": "experiments on the section of the glosso-pharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres",
    "b102": "Why is Wallerian degeneration in the CNS so slow?",
    "b103": "Multiple sclerosis: an immune or neurodegenerative disorder?",
    "b104": "maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease",
    "b105": "discovery of 7-oxo-2,4,5,7-tetrahydro-6 h-pyrazolo[3,4- c]pyridine derivatives as potent, orally available, and brain-penetrating receptor interacting protein 1 (rip1) kinase inhibitors: analysis of structure-kinetic relationships",
    "b106": "The \"dying-back\" phenomenon of motor neurons in ALS",
    "b107": "Axonal degeneration in motor neuron disease",
    "b108": "Increase in diameter of the axonal initial segment is an early change in amyotrophic lateral sclerosis",
    "b109": "Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis",
    "b110": "Necroptosis drives motor neuron death in models of both sporadic and familial ALS",
    "b111": "Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences",
    "b112": "Pharmacological inhibition of necroptosis protects from dopaminergic neuronal cell death in Parkinson's disease models",
    "b113": "Necrostatin-1 protection of dopaminergic neurons",
    "b114": "RIPK3 as a potential therapeutic target for Gaucher's disease",
    "b115": "How neuroinflammation contributes to neurodegeneration",
    "b116": "Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD",
    "b117": "Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease",
    "b118": "Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk",
    "b119": "Necroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression",
    "b120": "Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord",
    "b121": "Microglia and inflammation in Alzheimer's disease",
    "b122": "Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative",
    "b123": "deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in alzheimer's mice",
    "b124": "Necroptosis activation in Alzheimer's disease",
    "b125": "ripk1 mediates a disease-associated microglial response in alzheimer's disease",
    "b126": "Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase",
    "b127": "nec-1 alleviates cognitive impairment with reduction of a and tau abnormalities in app/ps1 mice",
    "b128": "Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer's disease",
    "b129": "25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome",
    "b130": "The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis",
    "b131": "Primary progressive multiple sclerosis: putting together the puzzle",
    "b132": "Defeating Alzheimer's disease and other dementias: a priority for European science and society",
    "b133": "Necroptosis increases with age and is reduced by dietary restriction",
    "b134": "Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways",
    "b135": "Association of mutations in TBK1 with sporadic and familial amyotrophic lateral sclerosis and frontotemporal dementia",
    "b136": "Autophagy in protein and organelle turnover",
    "b137": "Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease",
    "b138": "Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1",
    "b139": "The mechanistic links between proteasome activity, aging and age-related diseases",
    "b140": "Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice",
    "b141": "Cystatin F is a biomarker of prion pathogenesis in mice",
    "b142": "Microglial cystatin F expression is a sensitive indicator for ongoing demyelination with concurrent remyelination",
    "b143": "A unique microglia type associated with restricting development of Alzheimer's disease",
    "b144": "Neuroinflammation: microglia and T cells get ready to tango",
    "b145": "Macrophages in Alzheimer's disease: the blood-borne identity",
    "b146": "Protective roles for caspase-8 and cFLIP in adult homeostasis",
    "b147": "RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein",
    "b148": "RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis",
    "b149": "Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation",
    "b150": "Discovery of small molecule RIP1 kinase inhibitors for the treatment of pathologies associated with necroptosis",
    "b151": "cutting edge: ripk1 kinase inactive mice are viable and protected from tnf-induced necroptosis in vivo",
    "b152": "K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo",
    "b153": "RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome",
    "b154": "RIP1 kinase activity-dependent roles in embryonic development of Fadd-deficient mice",
    "b155": "Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1",
    "b156": "Structural basis of RIP1 inhibition by necrostatins",
    "b157": "Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases",
    "b158": "DNA-encoded library screening identifies benzo[b][1,4]oxazepin-4-ones as highly potent and monoselective receptor interacting protein 1 kinase inhibitors",
    "b159": "Necrostatin-1 improves long-term functional recovery through protecting oligodendrocyte precursor cells after transient focal cerebral ischemia in mice",
    "b160": "Necrostatin-1 attenuates inflammatory response and improves cognitive function in chronic ischemic stroke mice",
    "b161": "Necrostatin-1 reduces neurovascular injury after intracerebral hemorrhage",
    "b162": "Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice",
    "b163": "Necroptosis inhibitor necrostatin-1 promotes cell protection and physiological function in traumatic spinal cord injury",
    "b164": "A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model",
    "b165": "Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model",
    "b166": "ischemia reperfusion injury triggers tnf\u03b1 induced-necroptosis in rat retina",
    "b167": "Retinal ganglion cell (RGC) programmed necrosis contributes to ischemia-reperfusion-induced retinal damage",
    "b168": "Necrostatin-1 protects photoreceptors from cell death and improves functional outcome after experimental retinal detachment",
    "b169": "programmed necrosis, not apoptosis, is a key mediator of cell loss and damp-mediated inflammation in dsrna-induced retinal degeneration",
    "b170": "Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target",
    "b171": "Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis",
    "b172": "Genetic inhibition of receptor interacting protein kinase-1 reduces cell death and improves functional outcome after intracerebral hemorrhage in mice",
    "b173": "RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury",
    "b174": "RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition",
    "b175": "reactive astrocytes undergo m1 microglia/macrohpages-induced necroptosis in spinal cord injury",
    "b176": "RIP3 deficiency protects against traumatic brain injury (TBI) through suppressing oxidative stress, inflammation and apoptosis: dependent on AMPK pathway",
    "b177": "Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis"
}
